Call Us: (+95) 9 776644416

“Prudent Choice of SGLT2i: Translating Evidences into Clinical Practice” Academic Program

***Attendance E-Certificate will be provided after the academic program.

 

Dear Doctor,

📌Please be announced that there will be an academic program on “Prudent Choice of SGLT2i: Translating Evidences into Clinical Practice” organized by Myanmar Diabetes Association (MMDA) and Myanmar Society of Endocrinology & Metabolism (MSEM) at 1:00 PM on Sept 4, 2022 (Sunday).

 

The following topics will be covered in the academic program.
===========================================

The following topics will be covered in the academic program.
===========================================
1. What is the origin of SGLT2i and its unique mechanism of action?
2. Classes of SGLT2i and differences
3. What is the current status of indication for the SGLT2i in glycemic management of Diabetes?
4. How can we explain for the benefits of SGLT2i beyond glycemic control? (Cardiac benefits)
5. How can we explain for the benefits of SGLT2i beyond glycemic control? (Renal benefits)
6. What are the possible adverse effects of SGLT2i?
7. How can we know the diagnosis of Euglycemic Ketoacidosis?
8. What do you notice or observe the practice of our HCP as regard to SGLT2i in reality? / What advice can you give to our HCP for proper and effective use of SGLT2i?

 

You can access the academic program at
👉MMDA Facebook Page
https://www.facebook.com/myanmardiabetes
(or)
👉MMDA YouTube Channel
https://www.youtube.com/channel/UC7rez19SPSdsQDfcbQNQ6SA

 

For more details, you can contact info@myanmardiabetes.org.mm